Cássia C P Mendicino
Biographic Data
| ID | 5013836 |
|---|---|
| NAME | Cássia C P Mendicino |
| GIVEN NAMES | Cássia C P |
| FAMILY NAME | Mendicino |
| SIGNATURE | MENDICINO C C P |
| AFFILIATIONS | Universidade Federal de Minas Gerais |
| ORCID | 0000-0002-1627-292X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Immune recovery after antiretroviral therapy initiation
Immune recovery reflects health conditions. Our goal was to estimate the time it takes to achieve immune recovery and its associated factors, in people living with HIV (PLHIV), after antiretroviral therapy (ART) initiation. A historical cohort study was performed among PLHIV (> 18 years-old) in Minas Gerais State, Brazil, using data from healthcare databases. Patients initiating ART between 2009-2018, with T-CD4+ lymphocytes and viral load record…
HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women
Transgender (trans) women are disproportionally burdened by the HIV epidemic due to complex structural, psychosocial and biological factors. HIV pre-exposure prophylaxis (PrEP) is a biomedical prevention approach for people at substantial risk of acquiring HIV. This literature review assessed awareness, willingness to use, and barriers and facilitators for PrEP acceptability among trans women. A search was conducted through five databases and inc…
Effectiveness of second-line antiretroviral therapy
Including antiretroviral drug switches as a measure of ART failure could be more suitable than conventional measures to evaluate health outcomes in "real-world" settings. This is part of a historical cohort of HIV-infected adults who initiated ART from 2001-2005, and were followed up for a maximum of five years in three HIV/AIDS centers in Belo Horizonte, Brazil. Follow-up information included data from 2001-2010. All patients switched from first…
No prominent works on this page.
Effectiveness of second-line antiretroviral therapy
Including antiretroviral drug switches as a measure of ART failure could be more suitable than conventional measures to evaluate health outcomes in "real-world" settings. This is part of a historical cohort of HIV-infected adults who initiated ART from 2001-2005, and were followed up for a maximum of five years in three HIV/AIDS centers in Belo Horizonte, Brazil. Follow-up information included data from 2001-2010. All patients switched from first…
HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women
Transgender (trans) women are disproportionally burdened by the HIV epidemic due to complex structural, psychosocial and biological factors. HIV pre-exposure prophylaxis (PrEP) is a biomedical prevention approach for people at substantial risk of acquiring HIV. This literature review assessed awareness, willingness to use, and barriers and facilitators for PrEP acceptability among trans women. A search was conducted through five databases and inc…
Immune recovery after antiretroviral therapy initiation
Immune recovery reflects health conditions. Our goal was to estimate the time it takes to achieve immune recovery and its associated factors, in people living with HIV (PLHIV), after antiretroviral therapy (ART) initiation. A historical cohort study was performed among PLHIV (> 18 years-old) in Minas Gerais State, Brazil, using data from healthcare databases. Patients initiating ART between 2009-2018, with T-CD4+ lymphocytes and viral load record…
HIV/AIDS Research and Interventions (3 works) · Medicine (3 works) · Antiretroviral therapy (2 works) · Cohort (2 works) · HIV Research and Treatment (2 works) · Internal Medicine (2 works) · Proportional hazards model (2 works) · Viral load (2 works) · Cohort study (1 work) · Cumulative incidence (1 work)